Skip to content

Clinical trials

Completed Phase 3 Agammaglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Agammaglobulinemia Phase: Phase 3 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20051
20061
20121
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring3
Kedrion S.p.A.2
Bio Products Laboratory1
Grifols Therapeutics LLC1
Octapharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Agammaglobulinemia8
Common Variable Immunodeficiency5
Primary Immunodeficiency Diseases4
IgG Deficiency3
Wiskott-Aldrich Syndrome2
Hyper-IgM Immunodeficiency Syndrome1
Immunologic Deficiency Syndromes1
Leukemia, Lymphocytic, Chronic, B-Cell1
Severe Combined Immunodeficiency1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.